© Copyright Acquisition International 2024 - All Rights Reserved.

Article Image - Shining The Light On A Medical Marvel
Posted 18th December 2019

Shining The Light On A Medical Marvel

The fight against cancer has become one of the greatest in modern medical history, and scientific research continues to yield new medical methods for combating this disease. At the forefront of developing innovative technologies is Advanced Oncotherapy, a UK-based company focused on delivering proton-based radiotherapy. Heading into a new decade of medical advancement, discover why CEO Nicolas Serandour is being featured as one of Acquisition International’s CEOs to Watch in 2020.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Shining The Light On A Medical Marvel
Advanced Oncotherapy

The fight against cancer has become one of the greatest in modern medical history, and scientific research continues to yield new medical methods for combating this disease. At the forefront of developing innovative technologies is Advanced Oncotherapy, a UK-based company focused on delivering proton-based radiotherapy. Heading into a new decade of medical advancement, discover why CEO Nicolas Serandour is being featured as one of Acquisition International’s CEOs to Watch in 2020.

In 2019 alone, nearly nine million people will have died of cancer. If left unchecked, that figure could well rise to over thirteen million every year by 2030. That is a staggering 1,500 deaths per hour. With these statistics in mind, breakthrough technologies represent one of the greatest hopes for cancer patients of both the present and future. Innovative CEOs such as Nicolas Serandour are standing steadfast as medical vanguards, relentlessly pursuing start-of-the-art technologies that can be leveraged in the ongoing fight against cancer.

Conventional treatments for cancer patients include radiation therapy, which is used in up to sixty percent of cases. However, it can come with costly side effects for the patients. Healthy tissue can suffer, causing internal damage that is hard to repair. That’s where Advanced Oncotherapy’s ground-breaking solution comes in. Focused on proton therapy, also known as proton beam therapy, Nicolas has spearheaded a venture that he believes will revolutionise the way physicians treat cancer moving forward. What separates proton therapy from traditional radiation therapy is the ability to target cancerous cells in the body without causing significant damage to the surrounding healthy tissue.
Advanced Oncotherapy’s vision for the future is one where a more affordable, proton-based radiotherapy system saves the lives of countless more cancer patients than ever before. With this innovative new technology proving to be both cost-effective and clinically superior to existing systems, Nicolas wants to make this vision a reality. Since being at the firm, Nicolas has overseen the development of its proprietary proton-based technology, LIGHT®.

Developed in collaboration with the world-renowned CERN in Switzerland, LIGHT® represents the next step in proton beam therapy and particle acceleration that will change the way cancer is approached. LIGHT®’s compact design allows the delivery of proton beams onto a tumour with greater precision, even during organ movement. This is due to LIGHT®’s capability to change the dose and energy very quickly, which is important for an entire class of moving tumours (lung, pancreatic, liver).

Nicolas and his team are also capitalising on LIGHT®’s uniquely small beam size to position the device ahead in the race for delivering what is called “FLASH”: a faster, cheaper approach to proton therapy. A research collaboration with the Cleveland Clinic, that will evaluate the target conformity of proton minibeams, is a significant development as it marks a clear endorsement from one of the most prestigious healthcare institutions in the world.

“Advanced Oncotherapy’s vision for the future is to save the lives of countless more cancer patients than ever before.”

The company has many ongoing discussions and exclusivity arrangements across the world, including great interest from China. Rather than simply boast about a new piece of tech, and expect hospitals to buy it, Nicolas has instead focused on building relationships that are clinically beneficial for all involved. By enabling hospitals to be a part of developing this new particle accelerator and investigating its therapeutic uses, Advanced Oncotherapy and LIGHT® have rapidly become compelling partners.

Nicolas’ success as CEO of Advanced Oncotherapy will soon see the first LIGHT® system implemented in Harley Street, London. An iconic medical location, this latest development sees yet another success secured for Nicolas and his team. As a proton beam accelerator that is far more compact that traditional radiology equipment, LIGHT® being implemented in the basement of two terraced houses in London will hopefully prove that it can be implemented almost anywhere.

Of course, the mark of any great CEO is the ability to recognise the incredible work of the team around them. Since the beginning of his tenure with Advanced Oncotherapy, Nicolas has remained indebted to the outstanding work and devotion of his staff in pursuing their one goal together; to save lives. Nicolas instils in his staff the energy and desire to work collectively as a team in meeting technical milestones set almost thirty months ago. Hiring and partnering with high-calibre experts in radiation and proton therapy, the team Nicolas has built is as much a testament to his success as that of LIGHT® itself.

For Nicolas, the next step is getting LIGHT® into hospitals where it can truly change lives for the better. A well-considered implementation plan is already in place to successfully transform Advanced Oncotherapy into the undisputed commercial leader for proton-based therapy. As the next decade beckons, while Nicolas remains one of the most exciting leaders to watch within oncotherapy, it is his firm’s potential to radically advance humanity’s efforts to defeat cancer for good that is the real draw.

Company: Advanced Oncotherapy
Contact: advancedoncotherapy@fticonsulting.com
Website: https://www.avoplc.com/

Categories: Innovation, Leadership, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
Tapping into the American Psyche Using Market Sentiment
Innovation
12/12/2019Tapping into the American Psyche Using Market Sentiment

Most commonly used in the trading world, market sentiment refers to the overall attitude of investors towards a particular market. Now, Apple’s Steve Jobs famously said he didn’t pay attention to market research and, instead, aimed to give customers someth

Read Full PostRead - Eye Icon
DXCorr Design Inc. Architect in Embedded Physical IP
Innovation
02/08/2022DXCorr Design Inc. Architect in Embedded Physical IP

A pioneer in the semiconductor industry, DXCorr design is a product based semiconductor company that facilitates SoC design solutions with in-house IPs, incorporating complex memory SRAMs, CAMs, Multiports, memory subsystems, and standard cells.

Read Full PostRead - Eye Icon
Navigating the Personalization Trend: Incorporating Customized Visual Content into Your Corporate Identity
News
04/03/2024Navigating the Personalization Trend: Incorporating Customized Visual Content into Your Corporate Identity

Why settle for off-the-shelf when the game has changed? Customized visual content isn’t just a trend; it’s a cornerstone of corporate identity in today’s competitive landscape. It weaves the unique narrative of your brand and acts as a beacon

Read Full PostRead - Eye Icon
How Fintech Can Help Your Business
Finance
03/01/2023How Fintech Can Help Your Business

In the UK, there are 5.5 million businesses, so it’s important to make sure that you can run your business to the best of your ability. From making efficiency savings to ensuring your operations run smoothly, as business owners, there’s plenty to think abo

Read Full PostRead - Eye Icon
JP Morgan Advises Opko’s Acquisition of Bio-Reference Laboratorie
Finance
06/08/2015JP Morgan Advises Opko’s Acquisition of Bio-Reference Laboratorie

JP Morgan Advises Opko's Acquisition of Bio-Reference Laboratorie

Read Full PostRead - Eye Icon
4 Key Considerations When Investing in a Brand Ambassador
News
26/07/20224 Key Considerations When Investing in a Brand Ambassador

It’s no secret that social media has taken over the world. What started as a way for people to connect with friends and family has turned into a powerful marketing tool for businesses of all sizes. And one of the most effective ways to use social media f

Read Full PostRead - Eye Icon
Building upon Success
Innovation
20/06/2017Building upon Success

Most Outstanding for Restoration Architecture 2017 award winner NFA architects is an established and experienced practice formed of a senior director with dedicated architects, designers and technologists based in Kent. We interviewed the firm’s Nick Farnell

Read Full PostRead - Eye Icon
Seven Post-Pandemic Office Tech Trends to Look Out For
Innovation
08/04/2021Seven Post-Pandemic Office Tech Trends to Look Out For

As the pandemic has affected all aspects of our lives, the need for a new way of working is also affected. With that in mind, John Williams, Head of Marketing at Instant Offices reveals the top seven Proptech trends that aim to keep employee safe in a post-COV

Read Full PostRead - Eye Icon
Global Headwinds Fail to Stifle Dubai Property Boom
Finance
31/07/2023Global Headwinds Fail to Stifle Dubai Property Boom

The UAE’s real estate market has outpaced both advanced and emerging economies over the past two years, according to the Bank for International Settlements. As central banks around the world tighten monetary policy, Dubai is setting itself apart. The emi



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow